Regional metabolic effects of fluoxetine in major depression: Serial changes and relationship to clinical response

Biological Psychiatry

Volumn 48, Issue 8, 2000, Pages 830-843

  Mayberg, Helen S ^a,b,c   Brannan, Steven K ^a,b   Tekell, Janet L ^b   Silva, J Arturo ^b   Mahurin, Roderick K ^a,b   McGinnis, Scott ^a   Jerabek, Paul A ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b University of Texas Health Science Center   (United States)

^c ROTMAN RESEARCH INSTITUTE   (Canada)

Author keywords

Cingulate; Depression; Fluoxetine; Glucose metabolism; Hippocampus; Positron emission tomography; Prefrontal cortex; Striatum

Indexed keywords

FLUORODEOXYGLUCOSE F 18; FLUOXETINE; GLUCOSE;

ADULT; BRAIN REGION; BRAIN TOMOGRAPHY; CINGULATE GYRUS; CLINICAL ARTICLE; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DOUBLE BLIND PROCEDURE; GLUCOSE METABOLISM; HIPPOCAMPUS; HUMAN; IMAGE ANALYSIS; MALE; POSITRON EMISSION TOMOGRAPHY; PREFRONTAL CORTEX; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TISSUE SPECIFICITY; TREATMENT FAILURE; TREATMENT OUTCOME;

BRAIN; DEPRESSIVE DISORDER, MAJOR; DRUG ADMINISTRATION SCHEDULE; FLUOXETINE; GLUCOSE; HUMANS; LIMBIC SYSTEM; MALE; MIDDLE AGED; PREFRONTAL CORTEX; SEROTONIN UPTAKE INHIBITORS; TIME FACTORS; TOMOGRAPHY, EMISSION-COMPUTED; TREATMENT OUTCOME;

EID: 0034667295     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(00)01036-2     Document Type: Conference Paper

References (121)

1. A role for somatosensory cortices in the visual recognition of emotion as revealed by three-dimensional lesion mapping
2. Basal ganglia-thalamocortical circuits: Parallel substrates for motor, oculomotor, 'prefrontal' and 'limbic' functions
3. Reduction in serotonin transporter sites in prefrontal cortex is localized in suicide and widespread in major depression
4. Localized alterations in pre- and postsynaptic serotonin binding sites in the ventrolateral prefrontal cortex of suicide victims
5. Pindolol induces a rapid improvement of depressed patients with serotonin reuptake inhibitors
6. Primate serotonergic system: A review of human and animal studies and a report on Macaca fascicularis
7. The interaction between mood and cognitive function studied with PET
8. Reduction of prefrontal cortex glucose metabolism common to three types of depression
9. Changes in regional cerebral blood flow on recovery from depression
10. Regional cerebral blood flow in depression measured by positron emission tomography: The relationship with clinical dimensions
11. Early onset of therapeutic action in depression and greater efficacy of antidepressant treatments: Are they related?
12. Selective activation of post-synaptic 5HT1A receptors produces a rapid antidepressant response
13. Modulation of 5-HT release in the guinea-pig brain following long-term administration of antidepressant drugs
14. Serotonergic but not noradrenergic neurons in rat CNS adapt to long-term treatment with MAOIs
15. Serotonin and drug-induced therapeutic responses in major depression, obsessive compulsive and panic disorders
16. Cingulate metabolism predicts treatment response: A replication
17. Brain metabolic changes in major depressive disorder from pre to post-treatment with paroxetine
18. Effect of sertraline on regional metabolic rate in patients with affective disorder
19. Connectional networks within the orbital and medial prefrontal cortex of macaque monkeys
20. Presynaptic and postsynaptic modifications of the serotonin system by long-term administration of antidepressant treatments: An in vitro electrophysiologic study in the rat
21. A PET study of visuospatial attention
22. Monoamine innervation of cingulate cortex
23. Neural activity relating to generation and representation of galvanic skin conductance responses: A functional magnetic resonance imaging study
24. Influence of ascending serotonergic pathways on glucose use in the conscious rat brain. II. Effects of electrical stimulation of the rostral raphe nuclei
25. A suggestion for using powerful and informative tests of normality
26. The somatic marker hypothesis and the possible functions of the prefrontal cortex
27. Tricyclic antidepressants: Long term treatment increases responsivity of rat forebrain neurons to serotonin
28. Dissociation in prefrontal cortex of affective and attentional shifts
29. Neuropsychological dysfunction in depression: The relationship to regional cerebral blood flow
30. Dorsolateral prefrontal cortex dysfunction in the major psychoses: Symptom or disease specificity?
31. Serotonin in the basal ganglia: Functions and interactions with other neuronal pathways
32. PET imaging of serotonin 1A receptor binding in depression
33. Subgenual prefrontal cortex abnormalities in mood disorders
34. A functional anatomical study of unipolar depression
35. Neural plasticity to stress and antidepressant treatment
36. Functional classification of antidepressants based on antagonism of swim stress-induced fos-like immunoreactivity
37. The neuropsychological profile in unipolar depression
38. Alterations of serotonin release in the guinea pig orbitofrontal cortex: Relevance to the treatment of obsessive compulsive disorder
39. The neurobiological substrates of depression in Parkinson's disease: A hypothesis
40. Noninvasive functional brain mapping by change-distribution analysis of averaged PET images of H2150 tissue activity
41. 5HT1a receptors and 5HT1a-mediated responses: Effect on treatments that modify serotonergic neurotransmission
42. Subcortical projections of area 25 (subgenual cortex) of the macaque monkey
43. Prefrontal rTMS reduces relative perfusion locally and trans-synaptically
44. Topography of corticostriatal projections in nonhuman primates and implications for functional parcellation of the neostriatum
45. State changes in brain activity shown by the uptake of 99mTc-exametazime with single photon emission tomography in major depression before and after treatment
46. Neurotransmitter and neuromodulators in the basal ganglia
47. Long-term antidepressant treatments result in a tonic activation of forebrain 5HT(1A) receptors
48. A rating scale for depression
49. Arousal and emotions
50. Patterns of regional brain activity differentiate types of anxiety
51. The effects of ECT on brain glucose metabolism: A pilot FDG PET study
52. Are antidepressants all the same? Surveying the opinions of Australian psychiatrists
53. Initiation and adaptation: A paradigm for understanding psychotrophic drug action
54. Baseline cerebral hypermetabolism associated with carbamezepine response, and hypometabolism with nimodipine response in mood disorders
55. Primate cingulostriatal projection: Limbic striatal versus sensorimotor striatal input
56. A modality-independent approach to spatial normalization of tomographic images of human brain
57. Automated labeling of the human brain: A preliminary report on the development and evaluation of a forward-transform method
58. Neural activation during selective attention to subjective emotional responses
59. The varieties of emotional experience: A meditation on James-Lange theory
60. Psychomotor retardation and anhedonia in depression
61. Interactive effects in the anterior cingulate of sadness and selective attention: A PET study
62. Right hemisphere sensitivity to arousal and depression
63. Venlafaxine or buproprion responders but not non-responders show baseline prefrontal and paralimbic hypometabolism compared with controls
64. Tentative limbic system models for certain patterns of psychiatric disorders
65. Psychosomatic disease and the visceral brain. Recent developments bearing on the Papex theory of emotion
66. The retrosplenial cortex and emotion: New insights from functional neuroimaging of the human brain
67. Reduced midbrain serotonin transporter binding in depressed vs healthy subjects as measured by 123b-CIT SPECT
68. Frontal lobes and neurosurgery for psychiatric disorders
69. Protein kinase C in rat brain cortex and hippocampus: Effect of repeated administration of fluoxetine and desipramine
70. A serotonin transporter gene promoter polymorphism (5-HTTLPR) and prefrontal cortical binding in major depression and suicide
71. Left prefrontal glucose hypometabolism in the depressed state: A confirmation
72. Frontal 5-HT2A receptors studied in depressive patients during chronic treatment by selective serotonin reuptake inhibitors
73. Cingulate function in depression: A potential predictor of treatment response
74. Reciprocal limbic-cortical function and negative mood: Converging PET findings in depression and normal sadness
75. Frontal lobe dysfunction in secondary depression
76. Limbic-cortical dysregulation: A proposed model of depression
77. Disease and state-specific effects of mood challenge on rCBF
78. PET imaging of cortical S2-serotonin receptors following stroke: Lateralized changes and relationship to depression
79. Mapping functional alterations in the CNS with C14-deoxyglucose
80. Dissociation of autonomic and subjective responses to emotional slides in right hemisphere damaged patients
81. [F-18]-Altanserin binding to serotonin (5HT-2A) receptors in late-life depression and Alzheimer's disease
82. Architecture of connectivity within a cingul-fronto-parietal neurocognitive network for directed attention
83. 5-HT2A receptors in depression pre/post paroxetine
84. Prefrontal cortex 5-HT2 receptors in depression: A [18F] setoperone PET imaging study
85. A highly accurate method of localizing regions of neuronal activation in the human brain with positron emission tomography
86. The serotonergic and noradrenergic systems of the hippocampus: Interactions and effects of antidepressant treatments
87. Architecture of connectivity within a cingulo-fronto-parietal neurocognitive network for directed attention
88. Circuitous connections linking cerebral cortex, limbic system, and corpus striatum
89. Chronic antidepressant administration increases the expression of cAMP response element binding protein (CREB) in rat hippocampus
90. Effects of ECT on regional cerebral metabolic rate: A PET study
91. Regional cerebral blood flow in mood disorders, III. Treatment and clinical response
92. Antidepressant medication change in a clinical treatment setting: A comparison of the effectiveness of SSRI
93. Glial reduction in the subgenual prefrontal cortex in mood disorders
94. Comparison of prefrontal architecture and connections
95. The anterior cingulate cortex mediates processing selection in the Stroop attentional conflict paradigm
96. Localization of a human system for sustained attention by positron emission tomography
97. Regional cerebral blood flow changes following chronic administration of antidepressant drugs
98. Posttraumatic stress and depression. A neurochemical anatomy of the learned helplessness animal model
99. Tomographic measurement of local cerebral glucose metabolic rate in humans with (F18)2-fluoro-2-deoxydglucose: Validation of method
100. The orbitofrontal cortex
101. Brain serotonin-1A receptor binding measured by PET with 11C-Way-100635
102. Localized orbitofrontal and subcortical metabolic changes and predictors of response to paroxetine treatment in OCD
103. Hippocampal atrophy in recurrent major depression
104. Cerebral glucose metabolic response to combined total sleep deprivation and antidepressant treatment in geriatric depression
105. Measurement of local glucose utilization and its use in localization of functional activity in the CNS of animal and man
106. Time course of improvement under antidepressant treatment: A survival-analytical approach
107. Chronic antidepressant administration increases the expression of cAMP-specific phosphodiesterase 4A and 4B isoforms
108. Changes in prefrontal cortex and paralimbic activity in depression following two weeks of daily left prefrontal TMS
109. Treatment-resistant depression
110. 5-HT2A receptor-mediated regulation of brain-derived neurotrophic factor mRNA in the hippocampus and the neocortex
111. Human cingulate cortex: Surface features, flat maps, and cytoarchitecture
112. Cingulate cortex of the rhesus monkey, II: Cortical afferents
113. The emotional counting Stroop paradigm: A functional magnetic resonance imaging probe of the anterior cingulate affective division
114. Three dimensional statical analysis for CBF activation studies in human brain
115. Prediction of antidepressant effects of sleep deprivation on metabolic rates in ventral anterior cingulate and medial prefrontal cortex
116. Effect of sleep deprivation on brain metabolism of depressed patients
117. Decrease in brain serotonin 2 receptor binding in patients with major depression following desipramine treatment